Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
12/2000
12/06/2000EP1056439A1 Oral care compositions comprising chlorite
12/06/2000EP1056438A1 Oral care compositions comprising chlorite and methods
12/06/2000EP1056359A1 Product and method to reduce stress induced immune suppression
12/06/2000EP0683670B1 Wound-healing compositions containing iodine and a sugar
12/06/2000CN1275385A Medicinal composition for treating beriberi and preparation process thereof
12/06/2000CN1275372A Deodorising powder
12/06/2000CN1059122C Antipyretic and antitoxic particles and preparation process thereof
12/06/2000CN1059119C Traditional Chinese medicine for treating various headache and preparation process thereof
12/06/2000CN1059110C Medicine for treating psychosis and nerve system disease
12/06/2000CN1059095C Medicine for treating infectious oral disease
12/06/2000CN1059094C Epilepsy pill and producing process thereof
12/06/2000CN1059091C Medicine for treating fracture and bone disease, and preparation process thereof
12/06/2000CN1059088C Powder preparation for healing damaged skin
12/05/2000US6156797 Chloride ion for solutions and organic acid
12/05/2000US6156735 Arginine silicate inositol complex and use thereof
12/05/2000US6156350 Methods and kits for use in preventing restenosis
12/05/2000US6156347 Controlled release chromium picolinate
12/05/2000CA2184361C Solid dose forms containing bismuth
11/2000
11/30/2000WO2000071512A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071509A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071137A1 Electrolyte gels for maintaining hydration and rehydration
11/30/2000WO2000041725A3 Therapeutic compositions for metabolic bone disorders or bone metastases
11/30/2000WO2000038716A9 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/30/2000WO2000025829A3 Radiodense compositions
11/30/2000CA2382751A1 Inhibitors of factor xa
11/30/2000CA2374820A1 Inhibitors of factor xa
11/29/2000EP1055707A1 Autodispersing inverse latex
11/29/2000EP1054642A1 Light-activated tooth whitening composition and method of using same
11/29/2000EP0944429A4 Method for iron delivery to a patient by transfer from dialysate
11/29/2000CN1274599A Cancer treating medicine and its preparation
11/29/2000CN1274583A Calcium replenishing agent containing composite trace elements
11/29/2000CN1058898C Specific quick catalytic injection
11/29/2000CN1058868C Long-effect and broad-spectrum antibiotic granules and making method of its products thereof
11/29/2000CN1058867C Drug composition for curing bone tuberculosis in fumigation
11/28/2000US6153229 Stable glycerine iodine concentrate compositions
11/28/2000US6153210 Use of locally delivered metal ions for treatment of periodontal disease
11/23/2000WO2000069510A1 Energized trace elements
11/23/2000WO2000069427A1 Composition and method for treating limb ischemia
11/22/2000EP1053747A2 Composition for treating topical periodontal infection
11/22/2000EP1052999A1 Chelated 8-hydroxyquinoline for the treatment of epithelial lesions
11/22/2000EP1052987A1 Tablets to be crunched or sucked, comprising iron as active principle
11/22/2000EP0705255B1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes
11/22/2000CN1273859A Buccal lozenge for activating intelligent genes and increasing intelligence quotient
11/22/2000CN1273851A Chinese medicine for treating intraocular hemorrhage
11/22/2000CN1273850A Reagent for diagnosing eary urinary calculus
11/22/2000CN1273836A Fumaitong liquid and its preparing process
11/22/2000CN1273835A Chinese medicine for treating rheumatism
11/22/2000CN1273829A Medicinal composition for treating foot ringworm
11/22/2000CN1273828A Instant particles for supplementing nutrients needed per day
11/22/2000CN1273827A Disinfecting liquid for treating tinea and pile
11/22/2000CN1058624C Burns curing powder and its prepn. method
11/22/2000CN1058620C External-use Chinese patent drug for treating cancer, and its prodn. tech.
11/22/2000CN1058612C Ointment for treating nasal polyp
11/22/2000CN1058611C Antidiarrheal Chinese medicine
11/22/2000CN1058605C Feast drink
11/21/2000US6150398 By administering to a human a synergistic combination of paclitaxel and a dna crosslinking antineoplastic agent, such as cisplatin
11/21/2000US6150381 Methods of treating microbial infection and therapeutic formulations therefor
11/21/2000US6150346 Method and composition for treating or preventing osteoporosis
11/21/2000US6149948 Administering chromium complex for decreasing plasma cholesterol and/or triglyceride
11/21/2000US6149947 Compositions of oak bark extract related synthetic compositions and method of using same
11/21/2000US6149941 Taste of active pharmaceutical ingredients
11/21/2000US6149211 Inclusion of tooth whitening oxidation chemistries into slow releasing food products
11/16/2000WO2000067776A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
11/16/2000WO2000067769A1 Enhanced survival of cancer patients treated with erythropoietin and antitumor agents
11/16/2000WO2000067728A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/16/2000WO2000050045A3 Solution for injection containing a gold compound, calendula and belladonna extracts for the treatment of arthroses
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000CA2372782A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
11/16/2000CA2369594A1 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/15/2000EP1051976A2 Use of bisphosphate for the treatment of osteogenesis imperfecta
11/15/2000EP1051972A1 Nitric oxide donor composition and method for treatment of anal disorders
11/15/2000EP1051208A1 Hydrophilic coating for an intracorporeal medical device
11/15/2000EP1051184A1 Pharmaceutical composition comprising vanadium and/or salts thereof and its use to treat burns
11/15/2000EP1051150A1 Anti-enzyme compositions comprising ethylenediamine disuccinic acid
11/15/2000EP1051086A1 Dietetic composition in the form of a substitution salt for table salt
11/15/2000CN1273531A Chromium/biotin treatment of type II diabetes
11/15/2000CN1273529A Vitronection receptor antagonist
11/15/2000CN1273124A Powder prepared with colophony, realgar and 'Huangdan'
11/15/2000CN1273118A Chinese medicine for treating dental disease and its preparing process `
11/15/2000CN1273111A Ointment for treating skin tinea
11/15/2000CN1273100A Anticancer detoxicating pill and its preparing process
11/15/2000CN1273095A Exterior-applied medicine for treating dermatopathy and its preparing process
11/15/2000CN1273032A Water-soluble aromatic xibitane iodine
11/15/2000CN1058392C Disinfecting anti-inflammatory pill and preparing method
11/14/2000US6147094 Chelating agents and their metal chelates used to reduce cardiotoxic side-effects
11/14/2000US6147064 Oral 1α-hydroxyprevitamin D in composition and method for treating psoriasis
11/14/2000US6147060 Treatment of carcinomas using squalamine in combination with other anti-cancer agents
11/14/2000US6146649 Photobluing/whitening-resistant cosmetic/dermatological compositions comprising TiO2 pigments and deformable hollow particulates
11/09/2000WO2000066183A1 Vascular embolic materials having multifunctions
11/09/2000WO2000066133A1 Dietary supplement
11/09/2000WO2000066098A2 Vitamin d derivatives for the treatment of systemic lupus erythematosus
11/09/2000WO2000066093A2 Combined preparations comprising morpholine anthracyclines and anticancer agent
11/09/2000WO2000066090A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000WO2000066086A1 Anti-inflammatory bioactive glass particulates
11/09/2000WO2000066082A1 Anti-nausea compositions and methods
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000025763A3 Agents containing phenol derivatives having an inhibiting effect on the proliferation of tumour cells
11/09/2000CA2372834A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000CA2372225A1 Anti-nausea compositions and methods
11/08/2000EP1049478A1 Composition containing propargylamine for enhancing cancer therapy